Jonathan Sivakumar1, Lynn Chong2, Salena Ward2, Tom R Sutherland3, Matthew Read2, Michael W Hii2,4. 1. Department of Hepatobiliary and Upper GI Surgery, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia. Sivakumar.jonathan@gmail.com. 2. Department of Hepatobiliary and Upper GI Surgery, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia. 3. Department of Radiology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia. 4. Department of Surgery, St Vincent's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia.
Abstract
BACKGROUND: Fatty liver in obese patients increases the technical difficulty of bariatric surgery. Pre-operative weight loss with a very-low-calorie diet (VLCD) is commonly used to facilitate surgery. Few studies have quantified the systemic effect of rapid pre-operative weight loss on body composition. The objective of this study is to evaluate body composition changes in bariatric surgery patients undergoing a VLCD. METHODS: Body composition assessments were performed between August 2017 and January 2019 using dual-energy X-ray absorptiometry immediately before and after a 2-week VLCD at St Vincent's Hospital Melbourne. Data collected prospectively pre- and post-VLCD included total body weight, excess body weight, body mass index (BMI), lean body mass (LBM), fat mass (FM) and bone mineral content (BMC). The pre- and post-operative results were compared. RESULTS: Forty-four patients completed both the 2-week VLCD and body composition assessments. Following a 2-week VLCD, patients lost a mean of 4.5 kg (range - 0.3 to 9.5) in a total body weight and 8.8% (range - 0.9 to 17.1) of excess body weight, with a mean reduction in body mass index of 1.6 kg/m2 (range - 0.2 to 3.1). Loss of LBM was 2.8 kg and was significantly greater than loss of FM, 1.7 kg (p < 0.05). BMC changes were insignificant. CONCLUSION: A VLCD is an effective tool for pre-operative weight reduction. In this cohort, a large amount of the total weight loss was attributed to a loss of lean body mass. The impact of significant lean body mass loss and its relationship to short- and long-term health outcomes warrants further assessment.
BACKGROUND: Fatty liver in obesepatients increases the technical difficulty of bariatric surgery. Pre-operative weight loss with a very-low-calorie diet (VLCD) is commonly used to facilitate surgery. Few studies have quantified the systemic effect of rapid pre-operative weight loss on body composition. The objective of this study is to evaluate body composition changes in bariatric surgery patients undergoing a VLCD. METHODS: Body composition assessments were performed between August 2017 and January 2019 using dual-energy X-ray absorptiometry immediately before and after a 2-week VLCD at St Vincent's Hospital Melbourne. Data collected prospectively pre- and post-VLCD included total body weight, excess body weight, body mass index (BMI), lean body mass (LBM), fat mass (FM) and bone mineral content (BMC). The pre- and post-operative results were compared. RESULTS: Forty-four patients completed both the 2-week VLCD and body composition assessments. Following a 2-week VLCD, patients lost a mean of 4.5 kg (range - 0.3 to 9.5) in a total body weight and 8.8% (range - 0.9 to 17.1) of excess body weight, with a mean reduction in body mass index of 1.6 kg/m2 (range - 0.2 to 3.1). Loss of LBM was 2.8 kg and was significantly greater than loss of FM, 1.7 kg (p < 0.05). BMC changes were insignificant. CONCLUSION: A VLCD is an effective tool for pre-operative weight reduction. In this cohort, a large amount of the total weight loss was attributed to a loss of lean body mass. The impact of significant lean body mass loss and its relationship to short- and long-term health outcomes warrants further assessment.
Entities:
Keywords:
Bariatric; Body composition; Fat mass; Lean body mass; Very-low-calorie diet
Authors: Alexandra M Johnstone; Peter Faber; Eileen R Gibney; Gerald E Lobley; R James Stubbs; Mario Siervo Journal: Obes Res Clin Pract Date: 2014 Jan-Feb Impact factor: 2.288
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: E M P Backx; M Tieland; K J Borgonjen-van den Berg; P R Claessen; L J C van Loon; L C P G M de Groot Journal: Int J Obes (Lond) Date: 2015-10-16 Impact factor: 5.095
Authors: G Merra; S Gratteri; A De Lorenzo; S Barrucco; M A Perrone; E Avolio; S Bernardini; M Marchetti; L Di Renzo Journal: Eur Rev Med Pharmacol Sci Date: 2017-01 Impact factor: 3.507
Authors: Ramzi S Alami; John M Morton; Rob Schuster; Jie Lie; Barry R Sanchez; Anna Peters; Myriam J Curet Journal: Surg Obes Relat Dis Date: 2007-02-27 Impact factor: 4.734
Authors: L Busetto; C Pisent; D Rinaldi; P L Longhin; G Segato; F De Marchi; M Foletto; F Favretti; M Lise; G Enzi Journal: Obes Surg Date: 2000-12 Impact factor: 4.129
Authors: Fanny Buckinx; Francesco Landi; Matteo Cesari; Roger A Fielding; Marjolein Visser; Klaus Engelke; Stefania Maggi; Elaine Dennison; Nasser M Al-Daghri; Sophie Allepaerts; Jurgen Bauer; Ivan Bautmans; Maria Luisa Brandi; Olivier Bruyère; Tommy Cederholm; Francesca Cerreta; Antonio Cherubini; Cyrus Cooper; Alphonso Cruz-Jentoft; Eugene McCloskey; Bess Dawson-Hughes; Jean-Marc Kaufman; Andrea Laslop; Jean Petermans; Jean-Yves Reginster; René Rizzoli; Sian Robinson; Yves Rolland; Ricardo Rueda; Bruno Vellas; John A Kanis Journal: J Cachexia Sarcopenia Muscle Date: 2018-01-19 Impact factor: 12.910
Authors: Andrea Deledda; Stefano Pintus; Andrea Loviselli; Michele Fosci; Giovanni Fantola; Fernanda Velluzzi Journal: Int J Environ Res Public Health Date: 2021-11-17 Impact factor: 3.390
Authors: Dionne Sizoo; Loek J M de Heide; Marloes Emous; Tim van Zutphen; Gerjan Navis; André P van Beek Journal: Obes Surg Date: 2020-11-06 Impact factor: 4.129